Floatz logo

Therapeutic Asset Ratings

6,299 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Emavusertib
Hematopoietic And Lymphoid System Neoplasm
Curis, Inc.P1/2CC (45)
Emavusertib
Primary Central Nervous System Lymphoma
Curis, Inc.P1/2CC (45)
Enitociclib
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P1/2CC (45)
Entinostat
Human Papilloma Virus Infection
National Cancer Institute (NCI)P1/2CC (45)
Entinostat
Vaginal Cancer
National Cancer Institute (NCI)P1/2CC (45)
Entinostat
Vulva Cancer
National Cancer Institute (NCI)P1/2CC (45)
Entr-601-44
Duchenne Muscular Dystrophy
Entrada Therapeutics, Inc.P1/2CC (45)
Entrectinib
Central Nervous System Neoplasm
Hoffmann-La RocheP1/2CC (45)
Env-501
Cutaneous Melanoma
Hummingbird BioscienceP1/2CC (45)
Enzalutamide
Esophageal Cancer
Cancer Research UKP1/2CC (45)
Enzalutamide
Pancreatic Neoplasm
Nuvation Bio Inc.P1/2CC (45)
ep0062
Breast Tumor Luminal A Or B
Ellipses PharmaP1/2CC (45)
et140203 t cells
Liver And Intrahepatic Bile Duct Neoplasm
Eureka Therapeutics Inc.P1/2CC (45)
Etx-19477
Castration-Resistant Prostate Carcinoma
858 Therapeutics, Inc.P1/2CC (45)
Fog-001
Hepatocellular Carcinoma
Parabilis Medicines, Inc.P1/2CC (45)
Fruquintinib
Esophageal Cancer
Immunitas TherapeuticsP1/2CC (45)
Fulvestrant
Squamous Cell Lung Carcinoma
Terremoto Biosciences Inc.P1/2CC (45)
Gavo-Cel
Malignant Mesothelioma
TCR2 TherapeuticsP1/2CC (45)
gd2-cart01
Ewing Sarcoma
Bambino Gesù Hospital and Research InstituteP1/2CC (45)
gd2-cart01
Neuroblastoma
Bambino Gesù Hospital and Research InstituteP1/2CC (45)
gd2-cart01
Osteosarcoma
Bambino Gesù Hospital and Research InstituteP1/2CC (45)
Gdc-1261
Prostate Cancer
Genentech, Inc.P1/2CC (45)
Gdkm-100
Hepatocellular Carcinoma
Guangdong GD Kongming Biotech LLCP1/2CC (45)
gen1042
Head And Neck Squamous Cell Carcinoma
GenmabP1/2CC (45)
gen1107
Gastroesophageal Cancer
GenmabP1/2CC (45)
Showing 3551 to 3575 of 6,299 assets
PreviousPage 143 of 252Next